There was no significant difference between high or low expression of either RRM1 or ERCC1, detected by IHC or PCR, and any of the clinic-pathological variables analyzed, which included age, race, gender, tumor size, pathological depth (pT), histological grade and presence of metastatic lymph nodes (Table 2). Here, RRM1 is linked to neoplasm.